[引用][C] CMV retinitis: ganciclovir/monoclonal antibody
RB Pollard - Antiviral research, 1996 - Elsevier
Cytomegalovirus infection remains a major clinical problem in patients with AIDS and in
certain transplant situations. The most common manifestation of Cytomegalovirus (CMV) …
certain transplant situations. The most common manifestation of Cytomegalovirus (CMV) …
Polymerase Chain Reaction–Based Ganciclovir Resistance Testing of Ocular Fluids for Cytomegalovirus Retinitis
S Yeh, G Fahle, F Forooghian, LJ Faia… - Archives of …, 2012 - jamanetwork.com
Methods Patients diagnosed as having CMV retinitis who underwent ocular PCR analysis
for ganciclovir resistance from 2 tertiary referral institutions (National Eye Institute, National …
for ganciclovir resistance from 2 tertiary referral institutions (National Eye Institute, National …
Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS
GL Plosker, S Noble - Drugs, 1999 - Springer
Cidofovir is an antiviral nucleotide analogue with significant activity against cytomegalovirus
(CMV) and other herpesviruses. The drug is indicated for the treatment of CMV retinitis, a …
(CMV) and other herpesviruses. The drug is indicated for the treatment of CMV retinitis, a …
Cytomegalovirus infection: the point in 2001
D Salmon‐Ceron - HIV medicine, 2001 - Wiley Online Library
The incidence of cytomegalovirus (CMV) disease, one of the most prevalent opportunistic
infections in HIV‐infected persons in the early 1990s, has decreased by more than 80 …
infections in HIV‐infected persons in the early 1990s, has decreased by more than 80 …
A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS
SA Spector, T Weingeist, RB Pollard… - Journal of Infectious …, 1993 - academic.oup.com
This prospective, randomized, multicenter, controlled trial was designed to evaluate the
efficacy and safety of intravenous ganciclovir for the treatment of peripheral cytomegalovirus …
efficacy and safety of intravenous ganciclovir for the treatment of peripheral cytomegalovirus …
[HTML][HTML] Cytomegalovirus retinitis successfully treated with ganciclovir implant in a patient with blood ganciclovir resistance and ocular ganciclovir sensitivity
NK Bakshi, GA Fahle, I Sereti, H Wiley, RB Nussenblatt… - Eye, 2012 - nature.com
Case report A 52-year-old African female with AIDS and Hodgkin's lymphoma, after
successful chemotherapy, presented with recurrent CMV retinitis OS while on valganciclovir …
successful chemotherapy, presented with recurrent CMV retinitis OS while on valganciclovir …
Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study
SA Spector, DF Busch, S Follansbee… - Journal of Infectious …, 1995 - academic.oup.com
Abstract A phase I/II study evaluated the pharmacokinetics, tolerability, and antiviral activity
of oral ganciclovir in persons infected with human immunodeficiency virus (HIV). Oral …
of oral ganciclovir in persons infected with human immunodeficiency virus (HIV). Oral …
Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain
K Hamprecht, T Eckle, L Prix, C Faul… - The Journal of …, 2003 - academic.oup.com
A 9-month posttransplantation course of an allogeneic stem-cell transplant recipient (human
cytomegalovirus [HCMV] serostatus, donor positive/recipient negative), in whom ganciclovir …
cytomegalovirus [HCMV] serostatus, donor positive/recipient negative), in whom ganciclovir …
Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients
JE Marfori, MM Exner, GI Marousek, S Chou… - Journal of clinical …, 2007 - Elsevier
BACKGROUND: We report on two allogeneic stem cell transplant recipients who developed
cytomegalovirus disease associated with new viral mutations that conferred antiviral drug …
cytomegalovirus disease associated with new viral mutations that conferred antiviral drug …
Case study: rapid emergence of a cytomegalovirus UL97 mutant in a heart-transplant recipient on pre-emptive ganciclovir therapy
C Gilbert, MH LeBlanc, G Boivin - Herpes: the journal of …, 2001 - pubmed.ncbi.nlm.nih.gov
A cytomegalovirus (CMV) strain containing a mutation in the UL97 gene (Leu595Ser), which
is known to confer ganciclovir resistance, emerged rapidly in a heart-transplant recipient …
is known to confer ganciclovir resistance, emerged rapidly in a heart-transplant recipient …